english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

A critical eye

 Editorial  Welcome to the new, redesigned Prescrire International: a "critical eye" on drugs in Europe, with patients' interests front and centre.
1 January 2022

Crizanlizumab (Adakveo°) to prevent vaso-occlusive crises in sickle-cell disease: No proven clinical advantages

FEATURED REVIEW Is crizanlizumab more effective than hydroxycarbamide for patients with sickle-cell disease? Does it prevent vaso-occlusive crises and their serious complications when hydroxycarbamide is not sufficiently effective or cannot be used? What is its adverse effect profile?
Full review (5 pages) available for download by subscribers.
1 January 2022

In the January issue of Prescrire International: adverse effects of lamotrigine and biotin

FREE DOWNLOAD In our sample page from this month's issue, cardiac arrhythmias with lamotrigine, and biotin supplements' interference with laboratory tests.
Full text available for free download.
1 January 2022

Dravet syndrome: fenfluramine (Fintepla°) for children is unacceptable

Giving fenfluramine to children with Dravet syndrome (a rare and severe form of epilepsy), including those whose seizures remain frequent despite optimised treatment, increases the incidence of the most serious seizures and exposes them to a risk of serious cardiovascular adverse effects.
1 January 2022

Vitamin D drops for infants: mistakes to avoid

Errors and accidents are frequent with vitamin D supplied in dropper bottles. These include handling by children, eye exposure and, above all, overdose due to a mistake or related to a defective dropper bottle.
1 January 2022

Alzheimer's: yet another unwelcome drug

Despite aducanumab's lack of demonstrated efficacy in Alzheimer's disease, the scene is set to raise the hopes of patients and those close to them, and above all to promote the interests of the company and its shareholders.
1 January 2022

Dapagliflozin (Forxiga°) and chronic heart failure

FEATURED REVIEW An alternative to the sacubitril + valsartan combination, with the serious adverse effects common to all gliflozins.
Full review (3 pages) available for download by subscribers.
1 December 2021

In the December issue of Prescrire International - Teriparatide (Forsteo° and other brands) in pen injectors or cartridges: multidose formulations which must not be drawn into a syringe

FREE DOWNLOAD Drawing the contents of a cartridge or prefilled pen into a syringe carries a risk of dosing errors.
Full text available for free download.
1 December 2021

Full value

 Editorial  Packaging is a key determinant of a medicinal product's quality. It is high time that pharmaceutical companies and drug regulatory agencies appreciated the full value of high-quality drug packaging.
1 December 2021

The newly redesigned Prescrire International, from January 2022!

 COMING SOON  From January 2022, the new, redesigned Prescrire International casts a critical eye on new drugs authorised in Europe. Don't miss out!
1 December 2021

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90